This inventor holds 1 USPTO granted patent and 2 published patent applications, plus 1 CIPO patent. Top assignee: Modernatx, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Andrew Mckenzie: Lipid Nanoparticle Innovation
Introduction
Andrew Mckenzie is an inventor associated with Cambridge, Massachusetts, and ModernaTX, Inc. His patent work focuses on lipid compounds and compositions designed to deliver therapeutic agents into cells.
Latest Patents
Mckenzie is named on one patent, “Headgroup Lipid Compounds and Compositions for Intracellular Delivery of Therapeutic Agents.” The invention describes novel lipids and lipid nanoparticle compositions that may also contain phospholipids, structural lipids, and PEG lipids. These nanoparticles can carry therapeutic or prophylactic agents, including RNA, to mammalian cells or organs. Potential applications include regulating polypeptide, protein, or gene expression.
Career Highlights
Mckenzie’s listed patent reflects work on lipid nanoparticle technologies for intracellular delivery. His patent portfolio includes 1 patent.
Collaborations
The patent information identifies Mark Cornebise and Edward Hennessy as Mckenzie’s coworkers.
Conclusion
Andrew Mckenzie’s patent work at ModernaTX, Inc. centers on lipid-based delivery systems that may support the delivery of RNA and other therapeutic agents to cells and organs.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile